Bird & Bird has advised lead investor Forbion on the deal. Forbion completed the £35 million (c.$43 million) Series A financing in LoQus23 Therapeutics, to advance...
Bird & Bird has advised lead investor Forbion on the deal. Forbion completed the £35 million (c.$43 million) Series A financing in LoQus23 Therapeutics, to advance...
You must be a Standard 1 Year member to access this content.